Genting-backed Singaporean pharma startup TauRx claims $2.5b valuation

Genting-backed Singaporean pharma startup TauRx claims $2.5b valuation

Photo: Pixabay

Joyce Koh, Livia Yap

02 March, 2018

alzheimer'saxovant sciencesGentingLMTXTauRx Pharmaceuticals

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Singapore

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.